Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 308 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1492. Clear
Clear
Q1
BIOGEN for BIOGEN
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Manufacturing, Trade (domestic/foreign)
View →
Q1
WILLIAMS AND JENSEN, PLLC for PHRMA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Budget/Appropriations, Defense
View →
Q1
INTRA-CELLULAR THERAPIES, INC. for INTRA-CELLULAR THERAPIES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New York · House · Senate
Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Veterans
View →
Q1
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q1
MERCK & CO, INC. for MERCK & CO INC
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals
View →
Q1
W STRATEGIES, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid
View →
Q1
MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q1
MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
View →
Q1
MARSHALL & POPP, LLC for PFIZER, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $40,000.00 income
Health Issues, Budget/Appropriations
View →
Q1
MARSHALL & POPP, LLC for GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q1
MARSHALL & POPP, LLC for AMGEN USA INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Budget/Appropriations, Pharmacy, Copyright/Patent/Trademark
View →
Q1
YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $30,000.00 income
Health Issues
View →
Q1
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
W STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for MERCK & CO., INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
W STRATEGIES, LLC for GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q1
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q1
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate
Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code, Veterans
View →
Q1
THE NICKLES GROUP, LLC for NOVO NORDISK, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Previous Page 12 of 13 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem